Human infections due to Mycobacterium lentiflavum: First report in Iran

Iranian Journal of Microbiology

Volumn 2, Issue 1, 2010, Pages 27-29

  Shamaei, Masoud ^a   Marjani, M ^a   Farnia, P ^b   Tabarsi, P ^b   Mansouri, D ^a,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Mycobacterium lentiflavum; NTM

Indexed keywords

AMIKACIN; CYCLOSERINE; OFLOXACIN; PROTIONAMIDE;

ADULT; ANOREXIA; ARTICLE; CASE REPORT; CLINICAL ARTICLE; COUGHING; DRUG SENSITIVITY; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOCOMPROMISED PATIENT; IRAN; MIXED INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM LENTIFLAVUM; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SPUTUM SMEAR; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUBERCULIN TEST; WEIGHT REDUCTION; X-RAY COMPUTED TOMOGRAPHY;

EID: 84878200818     PISSN: 20083289     EISSN: 20084447     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculosis Mycobaterial Diseases. Am J Respir Crit Care Med 2003; 175: 367-416.
2. McNabb AD, Eisler K, Adile M, Amos M, Rodrigues G, Stephens WA, Black I, Renton J. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65)for routine identification of mycobacterium species isolated from clinical sources. J Clin Microbiol 2004; 42: 3000-3011.
3. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990’s. Clin Microbiol Rev 2003; 2: 319-354.
4. World Health organization. Guidelines for the programmatic management of drug resistance tuberculosis. WHO/ HTM / TB / 2006. 361. Geneva, Switzerland: WHO 2006.
5. Matos ED, Santana MA, de Santana MC, Mamede P, de Lira Bezerra B, Panao ED, et al. Nontuberculosis Mycobacteria at a Multi-resistant Tuberculosis Reference Center in Bahia: Clinical Epidemiological Aspects. Braz J Infect Dis 2004 Aug; 8 (4): 296-304.
6. Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. European Respire J. 2005; 25: 564-569.
7. Lind A, Larsson LO, Bentzon MW, Magnusson M, Olofson J, Sjögren I, et al. Sensitivity to sensitins and tuberculin in Swedish children. I. A study of school children in an urban area. Tubercle 1991; 72: 29-36.
8. Reznikov M, Robinson E. Serologically identical Battey mycobacteria from sputa of healthy piggery workers and lesions of pigs. Aust Vet J 1970; 46: 606-607.
9. Springer B, Wu WK, Bodmer T, Hasse G, Pfyffer GE, Kroppenstedt RM, et al. Isolation and Characterization of a unique group of slowly growing mycobacteria:description of Mycobacterium lentiflavum sp.Nov. J Clin Microbiol 1996: 34: 1100-1107.
10. Haase G, Kentrup H, Skopnik H, Springer B, Bottger EC. Mycobacterium lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis 1997; 25: 1245-6.
11. Tortoli E, Mattei R, Russo C, Scarparo C. Mycobacterium Lentiflavum an emerging pathogen? J Infect 2005; 52: 185-187.
12. Safdar A, Han XY. Mycobacterium lentiflavum, a recently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer patients and summary of reported cases of infection. Eur J Clin Microbiol Infect Dis 2005; 24: 554-558.
13. Holt JG, Krieg NR, Sneath PHA, Staley JT, William ST, editors. Bergey’s manual of systemic bacteriology Baltimore: Williams and Wilkins. 1994, 597P.
14. Kent PT, Kubica GP, Public health Mycobacteriology: A guide for the level III laboratory, Department of Health and Human Services, Centers for Diseases Control, Atlanta, Ga. 1985:P-36-138.
15. Molteni C, Gazzola L, Cesari M, Lombardi A, Salerno F, Tortoli E, et al. Mycobacterium lentiflavum infection in immunocompetent patient. Emerg Infect Dis 2005; 11:119-122.